These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9796959)
1. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Hawighorst H; Weikel W; Knapstein PG; Knopp MV; Zuna I; Schönberg SO; Vaupel P; van Kaick G Clin Cancer Res; 1998 Oct; 4(10):2305-12. PubMed ID: 9796959 [TBL] [Abstract][Full Text] [Related]
2. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867 [TBL] [Abstract][Full Text] [Related]
3. [Detection of angiogenesis-dependent parameters by functional MRI: correlation with histomorphology and evaluation of clinical relevance as prognostic factor using cervix carcinoma as an example]. Hawighorst H; Schaeffer U; Knapstein PG; Knopp MV; Weikel W; Schönberg SO; Essig M; van Kaick G Rofo; 1998 Nov; 169(5):499-504. PubMed ID: 9849600 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439 [TBL] [Abstract][Full Text] [Related]
5. Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Hawighorst H; Knapstein PG; Knopp MV; Vaupel P; van Kaick G MAGMA; 1999 Mar; 8(1):55-62. PubMed ID: 10383094 [TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis. Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442 [TBL] [Abstract][Full Text] [Related]
8. Different angiogenic pathways in human cervical cancers. Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730 [TBL] [Abstract][Full Text] [Related]
12. [Microvessel density, epithelial-stromal vascular cuffing and expression of vascular endothelial growth factor in human cervical carcinoma]. Yao JF; Ji YF; Shi YF Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 32(1):62-6. PubMed ID: 12640714 [TBL] [Abstract][Full Text] [Related]
14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915 [TBL] [Abstract][Full Text] [Related]
16. Tumor vascularity: a histological measure of angiogenesis and hypoxia. West CM; Cooper RA; Loncaster JA; Wilks DP; Bromley M Cancer Res; 2001 Apr; 61(7):2907-10. PubMed ID: 11306466 [TBL] [Abstract][Full Text] [Related]
17. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784 [TBL] [Abstract][Full Text] [Related]
18. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus. Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645 [TBL] [Abstract][Full Text] [Related]
19. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Fine BA; Valente PT; Feinstein GI; Dey T Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438 [TBL] [Abstract][Full Text] [Related]
20. [Dynamic MRI and tumor angiogenesis of breast cancer]. Yasumura K; Ogawa K; Yuasa Y; Hiramatsu H; Hiramatsu K; Kitajima M Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun; 60(7):379-88. PubMed ID: 10921297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]